AstraZeneca: Q1 2015 Results (AstraZeneca) - Apr 27, 2015 - Anticipated enrollment completion of P1 trial (NCT01248949) for solid tumors and ovarian cancer in Q2 2015; Anticipated topline data from P1 trial (NCT01248949) for solid tumors and ovarian cancer in Q3 2017
Anticipated enrollment status • Anticipated P1 data • Oncology • Ovarian Cancer
|